Recently, TBL1XR1 is reported to be overexpressed in multiple malignancies and contributes to carcinogenesis and tumor progression, including esophageal squamous cell cancer, cervical cancer, breast cancer, nasopharyngeal cancer, and hepatocellular carcinoma [10–14]. Here, TBL1XR1 is linked to breast carcinoma.